Skip to main content
Erschienen in: Current Obstetrics and Gynecology Reports 3/2019

16.07.2019 | Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

Prenatal Ultrasound Imaging for Placenta Accreta Spectrum (PAS): a Practical Guide

verfasst von: Frederic Chantraine, Sally L. Collins

Erschienen in: Current Obstetrics and Gynecology Reports | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Placenta accreta spectrum (PAS) is a rare pregnancy complication with an increasing incidence worldwide. PAS can cause serious maternal morbidity and even mortality at delivery. Ultrasound (US) is an excellent imaging modality for the diagnosis of PAS, but it must be used correctly and there is little standardised training in placental imaging available. The aim of this paper is to discuss US screening for PAS and provide practical advice on its use for antenatal diagnosis.

Recent Findings

Screening for PAS in a high-risk population (history of previous caesarean delivery (CD) and an anterior low-lying/praevia placenta) is possible in well-trained hands with high sensitivity and specificity. This can be performed in the first trimester but usually occurs around 24–28 weeks after the routine anomaly US. A detailed examination of the placental bed using the US signs defined by EW-AIP with an adequately filled bladder enables the operator to produce a detailed report fully outlining the anticipated findings at delivery. This facilitates an appropriate multi-disciplinary team (MDT) approach which is the goal for optimal PAS management.

Summary

Women with a history of previous CD and an anterior low-lying/praevia placenta need a detailed examination of the placenta by an experienced operator. The US examination should be undertaken systematically, and the risk factors and US signs reported in a way which is useful to the MDT.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta. Am J Obstet Gynecol. 1966;95:660–8.CrossRefPubMed Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta. Am J Obstet Gynecol. 1966;95:660–8.CrossRefPubMed
2.
Zurück zum Zitat Chantraine F, Braun T, Gonser M, Henrich W, Tutschek B. Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand. 2013;92(4):439–44.CrossRefPubMed Chantraine F, Braun T, Gonser M, Henrich W, Tutschek B. Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand. 2013;92(4):439–44.CrossRefPubMed
3.
Zurück zum Zitat Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7(12):e52893.CrossRefPubMedPubMedCentral Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7(12):e52893.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Morlando M, Sarno L, Napolitano R, Capone A, Tessitore G, Maruotti GM, et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand. 2013;92(4):457–60.CrossRefPubMed Morlando M, Sarno L, Napolitano R, Capone A, Tessitore G, Maruotti GM, et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand. 2013;92(4):457–60.CrossRefPubMed
5.
Zurück zum Zitat Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG. 2019;126(1):e1–e48.CrossRef Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG. 2019;126(1):e1–e48.CrossRef
6.
Zurück zum Zitat D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42(5):509–17.CrossRefPubMed D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42(5):509–17.CrossRefPubMed
7.
Zurück zum Zitat Society of Gynecologic O, American College of O, Gynecologists, the Society for Maternal-Fetal M, Cahill AG, Beigi R, et al. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219(6):B2–B16.CrossRef Society of Gynecologic O, American College of O, Gynecologists, the Society for Maternal-Fetal M, Cahill AG, Beigi R, et al. Placenta accreta spectrum. Am J Obstet Gynecol. 2018;219(6):B2–B16.CrossRef
8.
Zurück zum Zitat Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274–80.CrossRefPubMed Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274–80.CrossRefPubMed
9.
Zurück zum Zitat Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27–36.CrossRefPubMed Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27–36.CrossRefPubMed
10.
Zurück zum Zitat Panaiotova J, Tokunaka M, Krajewska K, Zosmer N, Nicolaides KH. Screening for morbidly adherent placenta in early pregnancy. Ultrasound Obstet Gynecol. 2019;53(1):101–6.CrossRefPubMed Panaiotova J, Tokunaka M, Krajewska K, Zosmer N, Nicolaides KH. Screening for morbidly adherent placenta in early pregnancy. Ultrasound Obstet Gynecol. 2019;53(1):101–6.CrossRefPubMed
11.
Zurück zum Zitat D’Antonio F, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteagudo A, Buca D, Forlani F, et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):176–83.CrossRefPubMed D’Antonio F, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteagudo A, Buca D, Forlani F, et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):176–83.CrossRefPubMed
12.
Zurück zum Zitat Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson CJ. First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar. Ultrasound Obstet Gynecol. 2003;21(3):220–7.CrossRefPubMed Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson CJ. First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar. Ultrasound Obstet Gynecol. 2003;21(3):220–7.CrossRefPubMed
13.
Zurück zum Zitat Cali G, Forlani F, Timor-Tritsch IE, Palacios-Jaraquemada J, Minneci G, D’Antonio F. Natural history of Cesarean scar pregnancy on prenatal ultrasound: the crossover sign. Ultrasound Obstet Gynecol. 2017;50(1):100–4.CrossRefPubMed Cali G, Forlani F, Timor-Tritsch IE, Palacios-Jaraquemada J, Minneci G, D’Antonio F. Natural history of Cesarean scar pregnancy on prenatal ultrasound: the crossover sign. Ultrasound Obstet Gynecol. 2017;50(1):100–4.CrossRefPubMed
14.
Zurück zum Zitat Cali G, Forlani F, Minneci G, Foti F, Di Liberto S, Familiari A, et al. First-trimester prediction of surgical outcome in abnormally invasive placenta using the cross-over sign. Ultrasound Obstet Gynecol. 2018;51(2):184–8.CrossRefPubMed Cali G, Forlani F, Minneci G, Foti F, Di Liberto S, Familiari A, et al. First-trimester prediction of surgical outcome in abnormally invasive placenta using the cross-over sign. Ultrasound Obstet Gynecol. 2018;51(2):184–8.CrossRefPubMed
15.
Zurück zum Zitat Cali G, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteaugudo A, Buca D, Forlani F, et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):169–75.CrossRefPubMed Cali G, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteaugudo A, Buca D, Forlani F, et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):169–75.CrossRefPubMed
16.
Zurück zum Zitat Birch Petersen K, Hoffmann E, Rifbjerg Larsen C, Svarre Nielsen H. Cesarean scar pregnancy: a systematic review of treatment studies. Fertil Steril. 2016;105(4):958–67.CrossRefPubMed Birch Petersen K, Hoffmann E, Rifbjerg Larsen C, Svarre Nielsen H. Cesarean scar pregnancy: a systematic review of treatment studies. Fertil Steril. 2016;105(4):958–67.CrossRefPubMed
17.
Zurück zum Zitat Zosmer N, Fuller J, Shaikh H, Johns J, Ross JA. Natural history of early first-trimester pregnancies implanted in Cesarean scars. Ultrasound Obstet Gynecol. 2015;46(3):367–75.CrossRefPubMed Zosmer N, Fuller J, Shaikh H, Johns J, Ross JA. Natural history of early first-trimester pregnancies implanted in Cesarean scars. Ultrasound Obstet Gynecol. 2015;46(3):367–75.CrossRefPubMed
18.
Zurück zum Zitat Timor-Tritsch IE, D'Antonio F, Calí G, Palacios-Jaraquemada J, Meyer J, Monteagudo A. Early first-trimester transvaginal ultrasound is indicated in pregnancy after previous Cesarean delivery: should it be mandatory? Ultrasound Obstet Gynecol. 2019. https://doi.org/10.1002/uog.20225. Timor-Tritsch IE, D'Antonio F, Calí G, Palacios-Jaraquemada J, Meyer J, Monteagudo A. Early first-trimester transvaginal ultrasound is indicated in pregnancy after previous Cesarean delivery: should it be mandatory? Ultrasound Obstet Gynecol. 2019. https://​doi.​org/​10.​1002/​uog.​20225.
19.
Zurück zum Zitat • Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218(1):75–87 A very good comparison between the pathophysiology of PAS and the corresponding US signs.CrossRefPubMed • Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218(1):75–87 A very good comparison between the pathophysiology of PAS and the corresponding US signs.CrossRefPubMed
20.
Zurück zum Zitat •• Maynard H, Zamudio S, Jauniaux E, Collins SL. The importance of bladder volume in the ultrasound diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140(3):332–7 This study clearly demonstrates the importance of performing US with a filled bladder when there is suspicion of PAS. CrossRefPubMed •• Maynard H, Zamudio S, Jauniaux E, Collins SL. The importance of bladder volume in the ultrasound diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018;140(3):332–7 This study clearly demonstrates the importance of performing US with a filled bladder when there is suspicion of PAS. CrossRefPubMed
21.
Zurück zum Zitat •• Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016;47(3):271–5 An international group of experts defined the US signs evident in PAS allowing a more standardised approach for clinical management and research, making studies comparable. It provides clear pictures of each sign. CrossRefPubMed •• Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016;47(3):271–5 An international group of experts defined the US signs evident in PAS allowing a more standardised approach for clinical management and research, making studies comparable. It provides clear pictures of each sign. CrossRefPubMed
22.
Zurück zum Zitat Jauniaux E, Collins SL, Jurkovic D, Burton GJ. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 2016;215(6):712–21.CrossRefPubMed Jauniaux E, Collins SL, Jurkovic D, Burton GJ. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 2016;215(6):712–21.CrossRefPubMed
23.
Zurück zum Zitat Cramer SF, Heller DS. Placenta accreta and placenta increta: an approach to pathogenesis based on the trophoblastic differentiation pathway. Pediatr Dev Pathol. 2016;19(4):320–33.CrossRefPubMed Cramer SF, Heller DS. Placenta accreta and placenta increta: an approach to pathogenesis based on the trophoblastic differentiation pathway. Pediatr Dev Pathol. 2016;19(4):320–33.CrossRefPubMed
24.
Zurück zum Zitat Chantraine F, Blacher S, Berndt S, Palacios Jaraquemada JM, Sarioglu N, Nisolle M, et al. Abnormal vascular architecture at the placental-maternal interface in placenta increta. Am J Obstet Gynecol. 2012;207:188.e1–9 Available olnline 06/Jul/2012.CrossRef Chantraine F, Blacher S, Berndt S, Palacios Jaraquemada JM, Sarioglu N, Nisolle M, et al. Abnormal vascular architecture at the placental-maternal interface in placenta increta. Am J Obstet Gynecol. 2012;207:188.e1–9 Available olnline 06/Jul/2012.CrossRef
25.
Zurück zum Zitat Matsuo K, Conturie CL, Lee RH. Snowman sign: a possible predictor of catastrophic abnormal placentation. Eur J Obstet Gynecol Reprod Biol. 2014;181:341–2.CrossRefPubMed Matsuo K, Conturie CL, Lee RH. Snowman sign: a possible predictor of catastrophic abnormal placentation. Eur J Obstet Gynecol Reprod Biol. 2014;181:341–2.CrossRefPubMed
26.
Zurück zum Zitat Schaaps JP, Tsatsaris V, Goffin F, Brichant JF, Delbecque K, Tebache M, et al. Shunting the intervillous space: new concepts in human uteroplacental vascularization. Am J Obstet Gynecol. 2005;192(1):323–32.CrossRefPubMed Schaaps JP, Tsatsaris V, Goffin F, Brichant JF, Delbecque K, Tebache M, et al. Shunting the intervillous space: new concepts in human uteroplacental vascularization. Am J Obstet Gynecol. 2005;192(1):323–32.CrossRefPubMed
27.
Zurück zum Zitat Alfirevic Z, Tang AW, Collins SL, Robson SC, Palacios-Jaraquemada J, Ad-hoc International AIPEG. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. Ultrasound Obstet Gynecol. 2016;47(3):276–8.CrossRefPubMed Alfirevic Z, Tang AW, Collins SL, Robson SC, Palacios-Jaraquemada J, Ad-hoc International AIPEG. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. Ultrasound Obstet Gynecol. 2016;47(3):276–8.CrossRefPubMed
28.
Zurück zum Zitat Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, et al. Evidence-based guidelines for the management of abnormally-invasive placenta (AIP): recommendations from the International Society for AIP. Am J Obstet Gynecol. 2019;220:511–26.CrossRefPubMed Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, et al. Evidence-based guidelines for the management of abnormally-invasive placenta (AIP): recommendations from the International Society for AIP. Am J Obstet Gynecol. 2019;220:511–26.CrossRefPubMed
29.
Zurück zum Zitat Jauniaux E, Ayres-De-Campos D, Langhoff- Roos J, Fox K, Collins S. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynecol Obstet. 2019;146:20–4.CrossRef Jauniaux E, Ayres-De-Campos D, Langhoff- Roos J, Fox K, Collins S. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynecol Obstet. 2019;146:20–4.CrossRef
Metadaten
Titel
Prenatal Ultrasound Imaging for Placenta Accreta Spectrum (PAS): a Practical Guide
verfasst von
Frederic Chantraine
Sally L. Collins
Publikationsdatum
16.07.2019
Verlag
Springer US
Erschienen in
Current Obstetrics and Gynecology Reports / Ausgabe 3/2019
Elektronische ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-019-00267-8

Weitere Artikel der Ausgabe 3/2019

Current Obstetrics and Gynecology Reports 3/2019 Zur Ausgabe

Environmental Exposures and Pregnancy Outcomes (N Grindler, Section Editor)

Paternal Environmental Toxicant Exposure and Risk of Adverse Pregnancy Outcomes

Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

Multidisciplinary Teams in the Management of Placenta Accreta Spectrum Disorders

Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

From Etiopathology to Management of Accreta Placentation

Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

Is There a Role for MRI in the Management of Placenta Accreta Spectrum?

Aberrant Placentation: Contemporary Management of Placenta Accreta (E Jauniaux, Section Editor)

Managing Placenta Accreta Spectrum Disorders (PAS) in Middle/Low-Resource Settings

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.